Addus HomeCare Corporation (NASDAQ: ADUS) is a Healthcare company (Medical - Care Facilities) with a market capitalization of $2.3B. The Maz Rating grades it against the other companies in its sector.
Addus HomeCare Corporation's current Maz Rating and its five factor grades are for members: log in to see them.
At $121.56, Addus HomeCare Corporation trades at 20.4x trailing earnings, 1.5x sales and 1.9x book value, with an EV/EBITDA of 12.9. Over the last twelve months it generated about $1.5B of revenue and $111M of net income. It runs a gross margin of 32.3%, an operating margin of 10.3% and a net margin of 7.4%. It shows return on equity of 9.8%, return on invested capital of 8.9% and a free cash flow yield of 6.3%. On the balance sheet: a debt-to-equity ratio of 0.06 and a current ratio of 1.64. Over the past 52 weeks the share price ranged from $87.95 to $131.59, with a beta of 0.75.
Addus HomeCare Corporation does not currently pay a dividend.
18 Wall Street analyst ratings cover the stock: 15 Buy, 2 Hold and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.